Skip to main content
All lobbying filings

Cavarocchi Ruscio Dennis Associates, L.L.C.

Cavarocchi Ruscio Dennis Associates, L.L.C. filed a Q1 report for Hereditary Hemorrhagic Telangiectasia Foundation on April 16, 2025, reporting $10,000 in lobbying income.

Lobbying for Hereditary Hemorrhagic Telangiectasia Foundation · patient advocacy organization for individuals suffering from a rare disease

As filed: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. for HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION.

All filings by Cavarocchi Ruscio Dennis Associates, L.L.C. · Everything Hereditary Hemorrhagic Telangiectasia Foundation has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 16, 2025
Income
$10,000
What the client paid this registrant for the period.
Client based in
Maryland

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

HR 1968, FY25 Full-Year Continuing Appropriations and Extensions Act; DoD research on vascular malformations

HR 8774/S 4921, FY25 Defense Appropriations Act and HR 1968, FY25 Full-Year Continuing Appropriations and Extensions Act; DoD research on vascular malformations; HR 9029/S 4942, FY 25 Labor-HHS Education Act, National HHT Center of Excellence Program

 Bills named in this filing 3
  • H.R. 1968
    Full-Year Continuing Appropriations and Extensions Act, 2025
  • H.R. 8774
    Department of Defense Appropriations Act, 2025
  • H.R. 9029
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem